Phillip P. Chan, Chief Executive Officer at Cytosorbents Corp (CTSO), bought 15,000 shares at $4.04 ($61K) on 2021-12-29, disclosed to the SEC on 2022-01-03.
Scheduled purchase ($61k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.04 | 100 | $404 | 0.7% |
| 2 | $4.05 | 9,438 | $38K | 62.9% |
| 3 | $4.05 | 5,462 | $22K | 36.4% |
| Total | $4.05 avg | 15,000 | $61K | 100% |
| Filing → |
| CTSO | BUY | 2026-06-15 | $105K | — | Filing → |
| CTSO | BUY | 2023-12-15 | $200K | — | Filing → |
| CTSO | BUY | 2022-12-09 | $7K | — | Filing → |